Cite

    Enderby, C. et al. (n.d.). Transition from intravenous or subcutaneous prostacyclin therapy to inhaled treprostinil in patients with pulmonary arterial hypertension: a retrospective case series. Journal of clinical pharmacy and therapeutics. pp. 496-500. [Online].